Who Owns BioStem Technologies Stock?
NASDAQ: BSEMHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.00%
- Held by insiders
- 28.68%
- Institutional holders
- 0
- Institutions 0.0%
- Insiders 28.7%
- Public and other 71.3%
Who owns BioStem Technologies stock?
Institutional investors own about 0.0% of BioStem Technologies's shares, spread across 0 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 28.68% of BSEM.
Summary generated from market data by MetaCap's automated system. Methodology
Frequently asked questions
What percentage of BioStem Technologies is owned by institutions?
Institutions own about 0.0% of BSEM shares and 0.0% of the public float.
How much of BioStem Technologies do insiders own?
Insiders, such as officers and directors, own about 28.68% of BSEM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.